Penumbra, Inc. (PEN) Valuation
Historical valuation analysis based on 500 data points (2024-09-26 to 2026-09-24)
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospita...
Penumbra, Inc. (PEN) currently trades at a P/E ratio of 73.91 (historical range: 53.97–521.76, median: 76.53), placing it at the 32th percentile — below its historical average, P/S ratio of 8.69 (range: 6.35–10.59, 54th percentile — near its historical average).
Over the historical period (2024-09-26 to 2026-09-24), Penumbra, Inc.'s P/E ratio has contracted by 67% over the observed period (from an average of 222.1 to 73.9).
Penumbra, Inc. trades below its historical valuation range, with most metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 73.91 | 53.97 | 76.53 | 521.76 | 32th | below its historical average |
| P/S Ratio | 8.69 | 6.35 | 8.67 | 10.59 | 54th | near its historical average |
| FCF Yield | 0.02 | 0.01 | 0.01 | 0.02 | 82th | cheap relative to its history |
Penumbra, Inc. (PEN) Valuation & P/E History
Penumbra, Inc. (PEN) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry currently trading at $319.72 with a market capitalization of $12.6 billion. This page provides historical valuation analysis for PEN based on 500 data points covering 2024-09-26 to 2026-09-24. The P/E ratio of 73.91 is below the historical median of 76.53, placing PEN at the 32th percentile of its valuation range. The P/S ratio of 8.69 compares to a median of 8.67.
PEN Valuation Metrics & Historical Range
The valuation table above shows Penumbra, Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether PEN is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests PEN is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Penumbra, Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is PEN Overvalued or Undervalued?
Penumbra, Inc. trades below its historical valuation range, with most metrics below their median levels. The overall valuation percentile of 43 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive PEN is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full PEN analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.PEN trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.